Transplant
Transplant
We’re here for you. Call us at 844-346-7222 or
find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.
26
Clinical Trials
Transplant
NA
Accepting Patients
nct/study# NA / PRO00006278
Analysis of stem cell products immunological parameters and recipient outcome in autologous and allogeneic peripheral blood stem cell transplantation
Learn More
Transplant
NA
Accepting Patients
nct/study# NA / CD34-REAGENT-SYSTEM-GVHD
This protocol is for the use of CliniMACS CD34 Reagent System in a single patient with relapsed AML. Patient received salvage chemo and planned stem cell boost for cytopenias. Since donor is a haplo, plan is to give CD34 selected cells with some t cell add back.
Learn More
Transplant
NA
Accepting Patients
nct/study# NA / SAMPLE-REPOSITORY-02-05-120
A Sample repository for Allogeneic unrelated HSCT
Learn More
Transplant
Phase III
Accepting Patients
nct/study# NCT03800758 / EXPRESSIVE-HELPING-TRIAL
A Randomized Controlled Trial Testing Expressive Helping for Stem Cell Transplant Patients
Learn More
Transplant
Phase II
Accepting Patients
nct/study# NCT03601442 / MAP-PRO2018-0751
Managed Access Program (MAP) to Provide Access to CTL019, for ALL or DLBCL Patients With Out of Specification Leukapheresis Product and/or Manufactured Tisagenlecleucel Out of Specification for Commercial Release
Learn More
Transplant
NA
Accepting Patients
nct/study# NA / ARLG2-SCENE-Y8
Screening for Colonization with Resistant Enterobacterales in Neutropenic Patients with Hematologic Malignancies (SCENE)
Learn MoreWe are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.